InvestorsHub Logo
Followers 15
Posts 1708
Boards Moderated 0
Alias Born 03/11/2014

Re: None

Friday, 05/02/2014 11:34:11 AM

Friday, May 02, 2014 11:34:11 AM

Post# of 707522
Has anyone here ever called Lisa Sher at 212.661.2220 for investors and asked why NWBO wrote the pr the way in which they did ie so vaguely worded re what will be presented at ASCO esp re trial results or with re to the efficacy data is still pending mumbo jumbo part of the pr where NWBO clearly said it is just a continue? Just wondering, really think you should interesting to hear what you might get out of her.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News